Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate federal actions can support this leadership, the Biotechnology Innovation Organization (BIO) […]
BIO tells Congress how to maintain US biotech leadership Read More »
The use of AI tools in the workplace is on the rise. This trend is equally true in the arena of patent practice. However,
Using AI In patent practice: Practical and ethical issues Read More »
The post-COVID era has been especially hard on patent lawyers working in the biopharma space. “I don’t think it’s an accident that during the
BIO IP Conference looks at academics and perceptions of IP Read More »
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed one of the most important factors enabling breakthroughs in fighting rare
Patient advocates urge action on PPRV to help fight rare disease Read More »
We sometimes imagine the inventor of a patent as a lone vanguard leading the charge toward innovation, but in the era of team research
Who invented what? BIO IP panel tackles joint inventorship Read More »
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the
Bayh-Dole at 45: Still an engine for innovation Read More »
Legislation to free up capital for small innovative firms by removing regulatory barriers for both companies and investors passed the House Dec. 11—a move
House passes BIO-backed legislation to increase access to capital Read More »
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation Read More »
Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees
BIO 2025 IP Conference: Challenging times for the laws that drive innovation Read More »
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines,
Oncologist warns PBM step therapy has ‘crossed a dangerous line’ Read More »
